ABC as in Arteriopathy, Bleeding, and Coronary disease: Disentangling the prognostic conundrum of patients undergoing percutaneous coronary intervention with concomitant peripheral artery disease

Key points The prognosis of patients undergoing percutaneous coronary intervention can be informed by attentive appraisal of bleeding risk and peripheral artery disease. While the predictive interplay between bleeding risk and peripheral artery disease is quite complex, the former prognostic factor seems more potent and capable of better guiding decision‐making. Future research is warranted to gauge the benefits of individualized antithrombotic and antiatherosclerotic regimens to improve long‐term prognosis in patients undergoing percutaneous coronary intervention.